Further work will therefore be required to determine if CG5888, the top GWA candidate (P = 2.80E-07), is capable of modifying hyperglycemia in the r4>Sirt1-RNAi model, and if so, in which tissues it is acting. Here, SIRT1 is linked to Hyperglycemia.